Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Free Thinking: From promise to practice: immuno-oncology in action

This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...

Inizio

Exploring the Opportunity For Halal In Healthcare

Published in Medical Marketing & Media November 2015

Inizio

Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets

Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets

Inizio

12 Challenges Big Pharma Faces in China

Published in eyeforpharma 16 November by Rachel Howard

Inizio

Using mobile “diary” research to capture patient-generated insights in COPD

Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients

Inizio

Biosimilars in 2018: EU doctors’ perceptions of RA drug market

Published in pharmaphorum October 2015 by Laurent Chanroux

Inizio

Webinar: Understanding the Patient Journey in China 2015

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

Inizio

Understanding Patient Willingness to Pay

Published in eyeforpharma 12 October by Rachel Howard

Inizio

- PMLiVE

CRISPR Therapeutics appoints Dr Tony Coles

He takes up a seat on the Swiss biopharma's board of directors

- PMLiVE

The changing role of the modern MSL

Medical science liaisons are engaging in broader conversations than ever before

- PMLiVE

The Maverick: giving medicines away free

Co-op biotech founder Andrew Hessel on how he wants to change the way medicines are discovered and paid for

- PMLiVE

The world is our laboratory

Janssen's Thomas Stark on his company's approach to innovation, collaboration and research

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links